Eastman Kodak is trading 6.75% down at $8.75, with no clear company-specific catalyst identified for the decline.
- Its recent pharmaceutical product expansion was announced October 28, not on the day of the decline.
- Broader markets, particularly technology stocks, were under pressure amid concerns about Big Tech earnings and AI spending, but available reporting does not directly link that sell-off to Eastman Kodak’s move.
- No reliable same-day trading-volume details were found, leaving the reason for the sharper decline unclear.